Aktie A2P0CL AVEO PHARMACEUTICALS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen AVEO Pharmaceuticals, Inc.

Aktien

A2P0CL

US0535883070

AVEO

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
AVEO Pharmaceuticals, Inc. Announces Executive Changes
Aveo Oncology Announces Publication of Long-Term Survival in Patients with Relapsed/Refractory Advanced Renal Cell Carcinoma Treated with Tivozanib: Analysis of the Phase Iii Tivo-3 Trial in the Oncologist
AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
AVEO Oncology Announces Completion of Enrollment in Pivotal Phase 3 TiNivo-2 Study of FOTIVDA(R) in Combination with OPDIVO(R) in Advanced Renal Cell Carcinoma
South Korean Stocks Climb on Demand Recovery Hopes from China; LG Chem Stocks Add 1%
AVEO Completes Acquisition by LG Chem
LG Chem Acquires US Biopharma Firm AVEO Pharmaceuticals
AVEO PHARMACEUTICALS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)
LG Chem Completes Acquisition of AVEO Oncology
AVEO Pharmaceuticals, Inc. Announces Management Changes
AVEO Oncology Appoints Martin Birkhofer as Its Chief Medical Officer
AVEO Pharmaceuticals, Inc.(NasdaqCM:AVEO) dropped from NASDAQ Composite Index
AVEO Pharmaceuticals, Inc.(NasdaqCM:AVEO) dropped from S&P Global BMI Index
AVEO Pharmaceuticals, Inc.(NasdaqCM:AVEO) dropped from S&P TMI Index
LG Chem, Ltd. completed the acquisition of AVEO Pharmaceuticals, Inc. from a group of shareholders.
AVEO Pharmaceuticals Receives CFIUS Clearance for LG Chem Merger
AVEO Pharmaceuticals : Merger Agreement - Form 8-K
AVEO PHARMACEUTICALS, INC. : Other Events (form 8-K)
AVEO Pharmaceuticals Stockholders Approve LG Chem Merger
AVEO Oncology Stockholders Approve Acquisition by LG Chem
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2P0CL Aktie
  4. Nachrichten AVEO Pharmaceuticals, Inc.
  5. Andere Sprachen